[Radiation therapy of pancreatic cancer].

[Radiation therapy of pancreatic cancer].
Cancer Radiother. 2016 Aug 11;
Authors: Huguet F, Mornex F, Orthuon A
Abstract
Currently, the use of radiation therapy for patients with pancreatic cancer is subject to discussion. In adjuvant setting, the standard treatment is 6 months of chemotherapy with gemcitabine and capecitabine. Chemoradiation (CRT) may improve the survival of patients with incompletely resected tumors (R1). This should be confirmed by a prospective trial. Neoadjuvant CRT is a promising treatment especially for patients with borderline resectable tumors. For patients with locally advanced tumors, there is no a standard. An induction chemotherapy followed by CRT for non-progressive patients reduces the rate of local relapse. Whereas in the first trials of CRT large fields were used, the treated volumes have been reduced to improve tolerance. Tumor movements induced by breathing should be taken in account. Intensity modulated radiation therapy allows a reduction of doses to the organs at risk. Whereas widely used, this technique is not recommended.
PMID: 27523418 [PubMed - as supplied by publisher]

Source: Cancer Radiotherapie - August 10, 2016 Category: Cancer & Oncology Authors: Huguet F, Mornex F, Orthuon A Tags: Cancer Radiother Source Type: research